Table 6.

Concentration (105 cells ml−1) of haemocyte sub-populations in C. gigas hemolymph samples during DCFH-DA analysis

18°C
30°C
C. calcitransT. suecicaT-IsoC. calcitransT. suecicaT-Iso
Control condition       
Granulocytes 1.0±0.05b,A 0.6±0.3a,b,A 0.5±0.2a,A 1.1±0.04b,A 0.6±0.2a,A 0.5±0.2a,A 
Hyalinocytes 2.0±0.2a,A 1.4±0.2a,A 1.5±0.2a,A 2.3±0.2b,A 1.5±0.3a,A 1.6±0.2a,A 
Small agranular cells 1.1±0.1a,A 0.8±0.2a,A 0.9±0.3a,A 1.1±0.1a,A 0.9±0.3a,A 0.9±0.2a,A 
With PMA       
Granulocytes 0.4±0.1a,B 0.5±0.2a,A 0.3±0.1a,A 0.5±0.1a,B 0.4±0.1a,A 0.3±0.1a,A 
Hyalinocytes 1.6±0.3a,A 1.3±0.4a,A 1.2±0.1a,A 1.8±0.4a,A 1.3±0.2a,A 1.3±0.1a,A 
Small agranular cells 0.9±0.1a,A 0.9±0.3a,A 0.8±0.2a,A 0.8±0.1a,A 0.8±0.2a,A 0.7±0.2a,A 
18°C
30°C
C. calcitransT. suecicaT-IsoC. calcitransT. suecicaT-Iso
Control condition       
Granulocytes 1.0±0.05b,A 0.6±0.3a,b,A 0.5±0.2a,A 1.1±0.04b,A 0.6±0.2a,A 0.5±0.2a,A 
Hyalinocytes 2.0±0.2a,A 1.4±0.2a,A 1.5±0.2a,A 2.3±0.2b,A 1.5±0.3a,A 1.6±0.2a,A 
Small agranular cells 1.1±0.1a,A 0.8±0.2a,A 0.9±0.3a,A 1.1±0.1a,A 0.9±0.3a,A 0.9±0.2a,A 
With PMA       
Granulocytes 0.4±0.1a,B 0.5±0.2a,A 0.3±0.1a,A 0.5±0.1a,B 0.4±0.1a,A 0.3±0.1a,A 
Hyalinocytes 1.6±0.3a,A 1.3±0.4a,A 1.2±0.1a,A 1.8±0.4a,A 1.3±0.2a,A 1.3±0.1a,A 
Small agranular cells 0.9±0.1a,A 0.9±0.3a,A 0.8±0.2a,A 0.8±0.1a,A 0.8±0.2a,A 0.7±0.2a,A 

DCFH-DA, 2′7′ -dichlorofluorescein diacetate; PMA, phorbol myristate acetate.

Different lower-case letters indicate significant difference between dietary treatments. Different upper-case letters indicate a significant effect of the analysis conditions (control vs PMA; mean ± s.d., N=3, ANOVA P<0.01 for dietary treatment; t-test P<0.05 for the PMA effect).

Close Modal

or Create an Account

Close Modal
Close Modal